220 related articles for article (PubMed ID: 35619045)
21. Emerging drugs for dementia with Lewy Bodies: a review of Phase II & III trials.
Tolea MI; Ezzeddine R; Camacho S; Galvin JE
Expert Opin Emerg Drugs; 2023 Dec; 28(3):167-180. PubMed ID: 37531299
[TBL] [Abstract][Full Text] [Related]
22. The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data.
Tousi B; Leverenz JB
Drug Des Devel Ther; 2021; 15():1811-1817. PubMed ID: 33976533
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic trials in dementia with Lewy bodies: a systematic review of the literature].
Sacrez M; Lamothe M; Rauch L; Botzung A; Blanc F
Geriatr Psychol Neuropsychiatr Vieil; 2021 Sep; 19(3):289-304. PubMed ID: 34609295
[TBL] [Abstract][Full Text] [Related]
24. Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies.
Camicioli R; Gauthier S
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S109-17. PubMed ID: 17469693
[TBL] [Abstract][Full Text] [Related]
25. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
Jellinger KA
Parkinsonism Relat Disord; 2022 Jul; 100():24-32. PubMed ID: 35691178
[TBL] [Abstract][Full Text] [Related]
26. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.
Molloy SA; Rowan EN; O'Brien JT; McKeith IG; Wesnes K; Burn DJ
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1323-8. PubMed ID: 16952917
[TBL] [Abstract][Full Text] [Related]
27. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
Tsuboi Y; Dickson DW
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
[TBL] [Abstract][Full Text] [Related]
28. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
[TBL] [Abstract][Full Text] [Related]
29. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the Interplay Between Time of Dementia and Cognitive Profiles in Lewy Body Dementias.
Palermo G; Belli E; Tommasini L; Morganti R; Frosini D; Nicoletti V; Tognoni G; Siciliano G; Bonuccelli U; Baldacci F; Ceravolo R
J Alzheimers Dis; 2021; 84(2):757-766. PubMed ID: 34602466
[TBL] [Abstract][Full Text] [Related]
31. The role of levodopa in the management of dementia with Lewy bodies.
Molloy S; McKeith IG; O'Brien JT; Burn DJ
J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1200-3. PubMed ID: 16107351
[TBL] [Abstract][Full Text] [Related]
32. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
[TBL] [Abstract][Full Text] [Related]
33. No Significant Difference in Cognitive Decline and Mortality between Parkinson's Disease Dementia and Dementia with Lewy Bodies: Naturalistic Longitudinal Data from the Swedish Dementia Registry.
Fereshtehnejad SM; Lökk J; Wimo A; Eriksdotter M
J Parkinsons Dis; 2018; 8(4):553-561. PubMed ID: 30103351
[TBL] [Abstract][Full Text] [Related]
34. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
Harding AJ; Broe GA; Halliday GM
Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
[TBL] [Abstract][Full Text] [Related]
35. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
36. Dementia with Lewy bodies: emerging drug targets and therapeutics.
Pope ED; Cordes L; Shi J; Mari Z; Decourt B; Sabbagh MN
Expert Opin Investig Drugs; 2021 Jun; 30(6):603-609. PubMed ID: 33899637
[No Abstract] [Full Text] [Related]
37. Systematic review of pharmacological interventions for people with Lewy body dementia.
Watts KE; Storr NJ; Barr PG; Rajkumar AP
Aging Ment Health; 2023 Feb; 27(2):203-216. PubMed ID: 35109724
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy of dementia with Lewy bodies.
Fernandez HH; Wu CK; Ott BR
Expert Opin Pharmacother; 2003 Nov; 4(11):2027-37. PubMed ID: 14596656
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
[TBL] [Abstract][Full Text] [Related]
40. Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.
Aarsland D; Mosimann UP; McKeith IG
J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):164-71. PubMed ID: 15312280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
